107eP Safety of ivosidenib in patients with mIDH1 CCA: Updated results from the phase IIIb ProvIDHe study. - Casadei Gardini, A.; Wilmink, H.; Bridgewater, J.A.; Macarulla Mercade, T.; Sim, H-W.; Verslype, C.; Roderburg, C.; Touchefeu, Y.; McDermott, R.; Kordes, M.; Lee, C-K.; Vogel, A.; et al. (Annals of Oncology, 2025)